In December 2023, the Wall Street Journal ran the headline, “The Medicare Gold Rush Is Slowing Down.” It followed this up one month later with, “It Is Going to Be a Bad Year (or More) for the Medicare Business.” Finally, last week we got the punchline: "Insurance Companies’ Medicare Pullback Is Here.” MA appears to be shifting from its rapid growth phase into a more mature and constrained market. Its enrollment and share of the Medicare population will likely keep rising for years, but the program’s economics, incentives, and experience are poised to tighten, leaving payers, providers, and patients with fewer gains to share. 
 
For payers, medical costs driven by higher utilization are already hitting their bottom lines. Sooner than later, Congress and CMS are likely to get serious about payment reform such that MA actually saves money compared to traditional Medicare, as it was intended. And before long, Baby Boomers will be entering their “breakdown years,” the final years of life where healthcare expenditures are most highly concentrated. All the prior authorizations and utilization management tactics that have providers fed up with MA plans are likely to worsen as payers struggle to maintain margins for an increasingly expensive, decreasingly capitated population of aging seniors. Patients, for their part, will first feel the sting of losing access to $0 premiums, supplemental benefits, and relatively broader networks that enticed them to sign up for MA plans. Then, should they ever get frustrated with their increasingly limited-network MA plan as their health needs grow, they’ll discover that they missed their six-month window to sign up for Medigap upon turning 65, meaning they’d face significant cost-exposure by switching over to traditional Medicare. If and when we find these stressors plaguing our seniors, their providers, and the MA payers, we may look back and realize we took what was a well-regarded Medicare program and managed to ruin it for everyone.